{"id":"NCT03226392","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma","officialTitle":"A 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-31","primaryCompletion":"2019-07-05","completion":"2019-08-01","firstPosted":"2017-07-21","resultsPosted":"2020-02-28","lastUpdate":"2021-10-07"},"enrollment":704,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"QAW039","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"QAW039","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A randomized, multicenter, double-blind, placebo- controlled parallel-group study to determine the efficacy and safety of QAW039, compared with placebo, when added to standard-of-care (SoC) asthma therapy in adult and adolescent (â‰¥ 12 years) patients with uncontrolled asthma with respect to change from baseline in forced expiratory volume in 1 second (FEV1) at the end of 12 weeks of treatment.","primaryOutcome":{"measure":"Change From Baseline in Pre-dose FEV1","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"QAW039","deltaMin":0.126,"sd":0.00177},{"arm":"Placebo","deltaMin":0.157,"sd":0.0177}],"pValues":[{"comp":"OG000 vs OG001","p":"0.214"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":5},"locations":{"siteCount":142,"countries":["United States","Brazil","Bulgaria","Canada","Colombia","Germany","Hungary","India","Israel","Italy","Peru","Puerto Rico","Russia","South Korea","Spain","Sweden","Tunisia","Vietnam"]},"refs":{"pmids":[],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=594"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":352},"commonTop":["Asthma","Nasopharyngitis","Viral upper respiratory tract infection","Headache","Upper respiratory tract infection"]}}